Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease

✍ Scribed by Martin Farlow; Steven E. Arnold; Christopher H. van Dyck; Paul S. Aisen; B. Joy Snider; Anton P. Porsteinsson; Stuart Friedrich; Robert A. Dean; Celedon Gonzales; Gopalan Sethuraman; Ronald B. DeMattos; Richard Mohs; Steven M. Paul; Eric R. Siemers

• Book ID: 118054272
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 570 KB
• Volume: 8
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2011.09.224